Indivior PLC (LSE:INDV) - Share price


Stock Report

Indivior PLC INDV

Last Price
GBX50.80

Day Change
-0.42|-0.82%

As of 18/09/2019
17:42:55 BST | GBX
Minimum 15 Minutes Delay.

Last Close51.22p
Day Range50.72 - 53.40
Mkt Cap374.30Mil
52-Wk Range20.98 - 278.10
Yield %1.98
ISINGB00BRS65X63
Volume1,429,871
P/E1.94
P/S0.38
P/CF1.26

Share Price

Total Returns 17/09/2019

 Chg (%)  
More ...
Indivior PLC-9.66 
FTSE 100 TR GBP3.02
 
Financials
201620172018
More ...
Income Statement
Turnover1,058.001,093.001,005.00
Operating Profit149.00193.00316.00
Net Profit35.0058.00275.00
Reported EPS0.050.080.37
Balance Sheet
Current Assets990.001,225.001,329.00
Non Current Assets219.00219.00218.00
Total Assets1,209.001,444.001,547.00
Current Liabilities1,030.00854.00818.00
Total Liabilities---
Total Equity-295.00-203.0066.00
Cash Flow
Operating Cash Flow470.00328.00319.00
Net Change in Cash225.00168.0062.00

Regulatory News

DateAuthor Headline
11/07/2019James Gard Reckitt Shares Rise After Suboxone Settlement
Consumer giant settles with US regulators over the marketing of an opioid addiction drug Suboxone by former subsidiary Invidior
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/08/2019PurchaseMs. Lorna Parker60.378,2825,000.00
08/08/2019PurchaseMr. Howard H. Pien0.7450,00036,795.00
08/08/2019PurchaseDr. Peter James Jonathan Bains60.7054,00032,777.00
07/08/2019PurchaseMr. Howard H. Pien0.7550,00037,336.00

Company Profile

Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE SmallCap ,FTSE All Share

Next Event 01/11/2019

Third Quarter Results
Ratios
Comp
More ...
PER (E)2.16
Div Yld (E)0.00
PEG (E)0.00
ROCE41.98
Op Mrgn0.31
EPS Grwth3.57
Dividends
PreviousLatest
More ...
Record Date18/09/1517/06/16
Ex-Div17/09/1516/06/16
Paid23/10/1529/07/16
Amnt2.087.30
Directors
More ...
Non-Executive Director, ChairmanMr. Howard H. Pien
Non-Executive DirectorTatjana A H May
Non-Executive DirectorMr. Daniel J. Phelan
Non-Executive DirectorDr. Peter James Jonathan Bains
Non-Executive DirectorMs. Lorna Parker
Non-Executive Director, Senior Independent DirectorMr. Daniel Tasse
Executive Director, Chief Executive OfficerMr. Shaun Thaxter
Non-Executive DirectorMr. A. Thomas McLellan
Executive Director, Chief Financial and Operations OfficerMark Crossley
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.